Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.
2.

Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.

Patyna S, Büttner S, Eckes T, Obermüller N, Bartel C, Braner A, Trautmann S, Thomas D, Geiger H, Pfeilschifter J, Koch A.

Prostaglandins Other Lipid Mediat. 2019 Oct;144:106348. doi: 10.1016/j.prostaglandins.2019.106348. Epub 2019 Jul 10.

PMID:
31301404
3.

CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD).

Gauer S, Holzmann Y, Kränzlin B, Hoffmann SC, Gretz N, Hauser IA, Goppelt-Struebe M, Geiger H, Obermüller N.

J Histochem Cytochem. 2017 Dec;65(12):743-755. doi: 10.1369/0022155417735513. Epub 2017 Oct 23.

4.

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease Patients with Paricalcitol in German and Austrian Clinical Practice (TOP Study).

Obermüller N, Rosenkranz AR, Müller HW, Hidde D, Veres A, Decker-Burgard S, Weisz I, Geiger H.

Int J Mol Sci. 2017 Sep 28;18(10). pii: E2057. doi: 10.3390/ijms18102057.

5.

Long-Term Vaptan Treatment of Idiopathic SIADH in an Octogenarian.

Büttner S, Bachmann J, Geiger H, Obermüller N.

J Clin Med. 2017 Mar 8;6(3). pii: E28. doi: 10.3390/jcm6030028.

6.

Kidney Injury Molecule-1 Is Specifically Expressed in Cystically-Transformed Proximal Tubules of the PKD/Mhm (cy/+) Rat Model of Polycystic Kidney Disease.

Gauer S, Urbschat A, Gretz N, Hoffmann SC, Kränzlin B, Geiger H, Obermüller N.

Int J Mol Sci. 2016 May 24;17(6). pii: E802. doi: 10.3390/ijms17060802.

7.

Short-term preconditioning enhances the therapeutic potential of adipose-derived stromal/stem cell-conditioned medium in cisplatin-induced acute kidney injury.

Overath JM, Gauer S, Obermüller N, Schubert R, Schäfer R, Geiger H, Baer PC.

Exp Cell Res. 2016 Mar 15;342(2):175-83. doi: 10.1016/j.yexcr.2016.03.002. Epub 2016 Mar 15.

PMID:
26992633
8.

Combined peri-ischemic administration of Bβ15-42 in treating ischemia reperfusion injury of the mouse kidney.

Urbschat A, Rupprecht K, Zacharowski K, Obermüller N, Scheller B, Holfeld J, Tepeköylü C, Hofmann R, Paulus P.

Microvasc Res. 2015 Sep;101:48-54. doi: 10.1016/j.mvr.2015.06.005. Epub 2015 Jun 24.

PMID:
26116861
9.

Endocrine testing for the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).

Pliquett RU, Obermuller N.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2017 Apr 16.

10.

Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease.

Zschiedrich S, Budde K, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hoerl WH, Obermüller N, Arns W, Pavenstädt H, Gaedeke J, Lindner TH, Faerber L, Wimmer P, Stork R, Eckardt KU, Walz G.

Nephrol Dial Transplant. 2016 Feb;31(2):284-9. doi: 10.1093/ndt/gfv077. Epub 2015 Apr 1.

PMID:
25832108
11.

Upper and lower urinary tract infections can be detected early but not be discriminated by urinary NGAL in adults.

Urbschat A, Obermüller N, Paulus P, Reissig M, Hadji P, Hofmann R, Geiger H, Gauer S.

Int Urol Nephrol. 2014 Dec;46(12):2243-9. doi: 10.1007/s11255-014-0831-x. Epub 2014 Sep 14.

PMID:
25218613
12.

Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure.

Porubsky S, Federico G, Müthing J, Jennemann R, Gretz N, Büttner S, Obermüller N, Jung O, Hauser IA, Gröne E, Geiger H, Gröne HJ, Betz C.

J Pathol. 2014 Sep;234(1):120-33. doi: 10.1002/path.4388. Epub 2014 Jul 25.

13.

Serum and urinary NGAL but not KIM-1 raises in human postrenal AKI.

Urbschat A, Gauer S, Paulus P, Reissig M, Weipert C, Ramos-Lopez E, Hofmann R, Hadji P, Geiger H, Obermüller N.

Eur J Clin Invest. 2014 Jul;44(7):652-9. doi: 10.1111/eci.12283.

PMID:
24837251
14.

The early activation of toll-like receptor (TLR)-3 initiates kidney injury after ischemia and reperfusion.

Paulus P, Rupprecht K, Baer P, Obermüller N, Penzkofer D, Reissig C, Scheller B, Holfeld J, Zacharowski K, Dimmeler S, Schlammes J, Urbschat A.

PLoS One. 2014 Apr 15;9(4):e94366. doi: 10.1371/journal.pone.0094366. eCollection 2014.

15.

The small fibrinopeptide Bβ15-42 as renoprotective agent preserving the endothelial and vascular integrity in early ischemia reperfusion injury in the mouse kidney.

Urbschat A, Zacharowski K, Obermüller N, Rupprecht K, Penzkofer D, Jennewein C, Tran N, Scheller B, Dimmeler S, Paulus P.

PLoS One. 2014 Jan 2;9(1):e84432. doi: 10.1371/journal.pone.0084432. eCollection 2014.

16.

Current developments in early diagnosis of acute kidney injury.

Obermüller N, Geiger H, Weipert C, Urbschat A.

Int Urol Nephrol. 2014 Jan;46(1):1-7. doi: 10.1007/s11255-013-0448-5. Epub 2013 May 15. Review.

PMID:
23673775
17.

Biomarkers of kidney injury.

Urbschat A, Obermüller N, Haferkamp A.

Biomarkers. 2011 Jul;16 Suppl 1:S22-30. doi: 10.3109/1354750X.2011.587129. Review.

PMID:
21707441
18.

Transitional cell carcinoma of the native urinary tract after kidney transplantation: recommendations following a long-term retrospective analysis.

Tsaur I, Karalis A, Blaheta R, Juengel E, Vallo S, Scheuermann EH, Kachel HG, Waaga-Gasser AM, Chandraker A, Obermüller N, Probst M.

Am J Med Sci. 2011 Jun;341(6):478-83. doi: 10.1097/MAJ.0b013e31820a87f7.

PMID:
21412138
19.

Transgenic overexpression of Anks6(p.R823W) causes polycystic kidney disease in rats.

Neudecker S, Walz R, Menon K, Maier E, Bihoreau MT, Obermüller N, Kränzlin B, Gretz N, Hoffmann SC.

Am J Pathol. 2010 Dec;177(6):3000-9. doi: 10.2353/ajpath.2010.100569.

20.

De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients.

Tsaur I, Obermüller N, Jonas D, Blaheta R, Juengel E, Scheuermann EH, Kachel HG, Karalis A, Probst M.

BJU Int. 2011 Jul;108(2):229-34. doi: 10.1111/j.1464-410X.2010.09856.x. Epub 2010 Nov 10.

21.

Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy.

Otto EA, Hurd TW, Airik R, Chaki M, Zhou W, Stoetzel C, Patil SB, Levy S, Ghosh AK, Murga-Zamalloa CA, van Reeuwijk J, Letteboer SJ, Sang L, Giles RH, Liu Q, Coene KL, Estrada-Cuzcano A, Collin RW, McLaughlin HM, Held S, Kasanuki JM, Ramaswami G, Conte J, Lopez I, Washburn J, Macdonald J, Hu J, Yamashita Y, Maher ER, Guay-Woodford LM, Neumann HP, Obermüller N, Koenekoop RK, Bergmann C, Bei X, Lewis RA, Katsanis N, Lopes V, Williams DS, Lyons RH, Dang CV, Brito DA, Dias MB, Zhang X, Cavalcoli JD, Nürnberg G, Nürnberg P, Pierce EA, Jackson PK, Antignac C, Saunier S, Roepman R, Dollfus H, Khanna H, Hildebrandt F.

Nat Genet. 2010 Oct;42(10):840-50. doi: 10.1038/ng.662. Epub 2010 Sep 12.

22.

Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center.

Tsaur I, Karalis A, Probst M, Blaheta RA, Scheuermann EH, Gossmann J, Kachel HG, Hauser IA, Jonas D, Obermüller N.

Cancer Sci. 2010 Nov;101(11):2430-5. doi: 10.1111/j.1349-7006.2010.01676.x.

23.

Everolimus in patients with autosomal dominant polycystic kidney disease.

Walz G, Budde K, Mannaa M, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, Hörl WH, Obermüller N, Arns W, Pavenstädt H, Gaedeke J, Büchert M, May C, Gschaidmeier H, Kramer S, Eckardt KU.

N Engl J Med. 2010 Aug 26;363(9):830-40. doi: 10.1056/NEJMoa1003491. Epub 2010 Jun 26. Erratum in: N Engl J Med. 2010 Nov 11;363(20):1977. N Engl J Med. 2010 Sep 16;363(12):1190.

24.

CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.

Gutwein P, Abdel-Bakky MS, Schramme A, Doberstein K, Kämpfer-Kolb N, Amann K, Hauser IA, Obermüller N, Bartel C, Abdel-Aziz AA, El Sayed el SM, Pfeilschifter J.

Am J Pathol. 2009 Jun;174(6):2061-72. doi: 10.2353/ajpath.2009.080960. Epub 2009 May 12.

25.

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.

Gutwein P, Schramme A, Sinke N, Abdel-Bakky MS, Voss B, Obermüller N, Doberstein K, Koziolek M, Fritzsche F, Johannsen M, Jung K, Schaider H, Altevogt P, Ludwig A, Pfeilschifter J, Kristiansen G.

Eur J Cancer. 2009 Feb;45(3):478-89. doi: 10.1016/j.ejca.2008.10.023. Epub 2008 Dec 11.

PMID:
19070478
26.

Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney.

Schramme A, Abdel-Bakky MS, Gutwein P, Obermüller N, Baer PC, Hauser IA, Ludwig A, Gauer S, Schäfer L, Sobkowiak E, Altevogt P, Koziolek M, Kiss E, Gröne HJ, Tikkanen R, Goren I, Radeke H, Pfeilschifter J.

Kidney Int. 2008 Aug;74(3):328-38. doi: 10.1038/ki.2008.181. Epub 2008 May 14.

27.

Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine.

Bartel C, Obermüller N, Rummel MJ, Geiger H, Hauser IA.

Clin Nephrol. 2008 Apr;69(4):285-9.

PMID:
18397703
28.

IL-18 is expressed in the intercalated cell of human kidney.

Gauer S, Sichler O, Obermüller N, Holzmann Y, Kiss E, Sobkowiak E, Pfeilschifter J, Geiger H, Mühl H, Hauser IA.

Kidney Int. 2007 Nov;72(9):1081-7. Epub 2007 Aug 8.

29.

Synergistic induction of osteopontin by aldosterone and inflammatory cytokines in mesangial cells.

Gauer S, Hauser IA, Obermüller N, Holzmann Y, Geiger H, Goppelt-Struebe M.

J Cell Biochem. 2008 Feb 1;103(2):615-23.

PMID:
17546625
30.

Distinct immunohistochemical expression of osteopontin in the adult rat major salivary glands.

Obermüller N, Gassler N, Gretz N, Kränzlin B, Hoffmann S, Geiger H, Gauer S.

J Mol Histol. 2006 Jan;37(1-2):53-60. Epub 2006 Jul 3.

PMID:
16817053
31.

Expression of acyl-CoA synthetase 5 in human endometrium and in endometrioid adenocarcinomas.

Gassler N, Yang SH, Keith M, Helmke BM, Schirmacher P, Obermüller N.

Histopathology. 2005 Nov;47(5):501-7.

PMID:
16241998
32.

Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/+) rat.

Brown JH, Bihoreau MT, Hoffmann S, Kränzlin B, Tychinskaya I, Obermüller N, Podlich D, Boehn SN, Kaisaki PJ, Megel N, Danoy P, Copley RR, Broxholme J, Witzgall R, Lathrop M, Gretz N, Gauguier D.

J Am Soc Nephrol. 2005 Dec;16(12):3517-26. Epub 2005 Oct 5.

33.

Coeliac disease is associated with impaired expression of acyl-CoA-synthetase 5.

Obermüller N, Keith M, Kopitz J, Autschbach F, Schirmacher P, Gassler N.

Int J Colorectal Dis. 2006 Mar;21(2):130-4. Epub 2005 Apr 5.

PMID:
15809837
34.

Characterization of metaplastic and heterotopic epithelia in the human gastrointestinal tract by the expression pattern of acyl-CoA synthetase 5.

Gassler N, Obermüller N, Keith M, Schirmacher P, Autschbach F.

Histol Histopathol. 2005 Apr;20(2):409-14. doi: 10.14670/HH-20.409.

PMID:
15736044
35.

Immunohistochemical and mRNA localization of the angiotensin II receptor subtype 2 (AT2) in follicular granulosa cells of the rat ovary.

Obermüller N, Gentili M, Gauer S, Gretz N, Weigel M, Geiger H, Gassler N.

J Histochem Cytochem. 2004 Apr;52(4):545-8.

PMID:
15034006
36.

Impaired expression of acyl-CoA-synthetase 5 in epithelial tumors of the small intestine.

Gassler N, Schneider A, Kopitz J, Schnölzer M, Obermüller N, Kartenbeck J, Otto HF, Autschbach F.

Hum Pathol. 2003 Oct;34(10):1048-52.

PMID:
14608540
37.

Distinct expression of calnexin in major human salivary glands.

Gassler N, Bohn J, Schnölzer M, Scheuerer J, Obermüller N, Otto HF, Autschbach F.

Histol Histopathol. 2003 Jan;18(1):121-7. doi: 10.14670/HH-18.121.

PMID:
12507291
38.

Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum.

Gassler N, Autschbach F, Gauer S, Bohn J, Sido B, Otto HF, Geiger H, Obermüller N.

Scand J Gastroenterol. 2002 Nov;37(11):1286-95.

PMID:
12465727
39.

Altered expression pattern of polycystin-2 in acute and chronic renal tubular diseases.

Obermüller N, Cai Y, Kränzlin B, Thomson RB, Gretz N, Kriz W, Somlo S, Witzgall R.

J Am Soc Nephrol. 2002 Jul;13(7):1855-64.

40.

Cerebral localization and regulation of the cell volume-sensitive serum- and glucocorticoid-dependent kinase SGK1.

Wärntges S, Friedrich B, Henke G, Duranton C, Lang PA, Waldegger S, Meyermann R, Kuhl D, Speckmann EJ, Obermüller N, Witzgall R, Mack AF, Wagner HJ, Wagner A, Bröer S, Lang F.

Pflugers Arch. 2002 Feb;443(4):617-24. Epub 2001 Nov 9.

PMID:
11907829
41.

Impaired endocytosis may represent an obstacle to gene therapy in polycystic kidney disease.

Witzgall R, Kränzlin B, Gretz N, Obermüller N.

Kidney Int. 2002 Jan;61(1 Suppl):S132-7.

42.

Regulation of clusterin expression following spinal cord injury.

Klimaschewski L, Obermüller N, Witzgall R.

Cell Tissue Res. 2001 Nov;306(2):209-16.

PMID:
11702232
43.

Distinct expression of endothelin receptor subtypes A and B in luteinized human granulosa cells.

Gentili M, Obermüller N, Schleich HG, Melchert F, Weigel M.

Horm Metab Res. 2001 Oct;33(10):573-6.

PMID:
11607875
44.

Expression of clusterin in Crohn's disease of the terminal ileum.

Gassler N, Autschbach F, Heuschen G, Witzgall R, Otto HF, Obermüller N.

Histol Histopathol. 2001 Jul;16(3):755-62. doi: 10.14670/HH-16.755.

PMID:
11510965
45.

Inflammatory bowel disease is associated with changes of enterocytic junctions.

Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermüller N, Otto HF, Autschbach F.

Am J Physiol Gastrointest Liver Physiol. 2001 Jul;281(1):G216-28.

46.

Changes of AT(2) receptor levels in the rat adrenal cortex and medulla induced by bilateral nephrectomy and its modulation by circulating ANG II.

Peters B, Clausmeyer S, Teubner P, Obermüller N, Kränzlin B, Gretz N, Inagami T, Peters J.

J Histochem Cytochem. 2001 May;49(5):649-56.

PMID:
11304803
47.

An endocytosis defect as a possible cause of proteinuria in polycystic kidney disease.

Obermüller N, Kränzlin B, Blum WF, Gretz N, Witzgall R.

Am J Physiol Renal Physiol. 2001 Feb;280(2):F244-53.

48.

A possible role for metalloproteinases in renal cyst development.

Obermüller N, Morente N, Kränzlin B, Gretz N, Witzgall R.

Am J Physiol Renal Physiol. 2001 Mar;280(3):F540-50.

49.

An ever-expanding story of cyst formation.

Gallagher AR, Obermüller N, Cedzich A, Gretz N, Witzgall R.

Cell Tissue Res. 2000 Jun;300(3):361-71. Review.

PMID:
10928266
50.

The rat pkd2 protein assumes distinct subcellular distributions in different organs.

Obermüller N, Gallagher AR, Cai Y, Gassler N, Gretz N, Somlo S, Witzgall R.

Am J Physiol. 1999 Dec;277(6):F914-25. doi: 10.1152/ajprenal.1999.277.6.F914.

PMID:
10600939

Supplemental Content

Loading ...
Support Center